Skip to content

Generate Biomedicines, Inc. GENB Total Operating Expenses

Total Operating Expenses at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$112.33M+40.0%
Open Text logo
Open TextOTEX
$736.06M+6.8%
IPG Photonics logo
IPG PhotonicsIPGP
$107.24M+21.9%
RLI logo
RLIRLI
$28.28M+5.2%
Alignment Healthcare logo
Alignment HealthcareALHC
$1.22B+30.8%
GitLab logo
GitLabGTLB
$242.42M+8.2%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total operating expenses?
Generate Biomedicines, Inc. (GENB) reported total operating expenses of $71.34M in Q1 2026.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.